Ans T. Van Der Ploeg
Rotterdam, ZH 3015GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 183 publications
Bayesian multivariate linear mixed-effects models with varied association structures.
Journal: Statistical methods in medical research
Published: June 30, 2026
Central nervous system histopathological findings in classic infantile Pompe disease: a systematic review with clinical relevance.
Journal: Journal of neurology
Published: May 07, 2026
Quantitative Muscle MRI of the Lower Extremities Reveals Different Patterns of Involvement in Classic Infantile and Young Late-Onset Pompe Patients.
Journal: Journal of inherited metabolic disease
Published: March 01, 2026
Managing Pompe Disease and Enzyme Replacement Therapy During Pregnancy: Challenges and Considerations.
Journal: European journal of neurology
Published: February 27, 2026
Correction: Can Alpha-Glucosidase Activity in Plasma or Leukocytes Serve as a Biomarker for Future Gene Therapy in Classic Infantile Pompe Disease?
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: December 15, 2025
Can Alpha-Glucosidase Activity in Plasma or Leukocytes Serve as a Biomarker for Future Gene Therapy in Classic Infantile Pompe Disease?
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: November 09, 2025
Epilepsy Is Part of the CNS Phenotype in Classic Infantile Pompe Disease.
Journal: Neurology. Genetics
Published: October 31, 2025
Population Pharmacokinetic/Pharmacodynamic Modeling of Therapeutic Enzymes in Lysosomal Storage Diseases.
Journal: Clinical pharmacokinetics
Published: October 31, 2025
A comprehensive study on the effect of alglucosidase alpha and immunomodulation on survival, motor and cardiac outcome, creatine kinase and antibody titers in classic infantile Pompe disease: the Monza experience.
Journal: Current opinion in immunology
Published: October 18, 2025
Unfavorable cardiovascular risk profile without increased event prevalence in late-onset Pompe disease: an individually matched cohort study.
Journal: Orphanet journal of rare diseases
Published: September 22, 2025
Antibody formation and efficacy of enzyme replacement therapy in adults with Pompe disease: Unlocking long-term insights.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: August 15, 2025
Last Updated: 09/26/2026